Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer

被引:12
作者
Cheng, Hongyan [1 ,2 ]
Wang, Shang [1 ,2 ]
Luan, Wenqing [1 ,2 ]
Ye, Xue [1 ,2 ]
Dou, Sha [1 ]
Tang, Zhijian [1 ]
Zhu, Honglan [1 ]
Lin, Peter Ping [3 ]
Li, Yi [1 ]
Cui, Heng [1 ,2 ]
Chang, Xiaohong [1 ,2 ]
机构
[1] Peking Univ Peoples Hosp, Dept Obstet & Gynecol, 11 South Ave, Beijing 100044, Peoples R China
[2] Peking Univ Peoples Hosp, Ctr Gynecol Oncol, Beijing 100044, Peoples R China
[3] Cytelligen, San Diego, CA 92121 USA
基金
中国国家自然科学基金;
关键词
OC; CTC; CTEC; chromosome; 8; aneuploidy; SE-iFISH; CIRCULATING TUMOR-CELLS; EPITHELIAL OVARIAN; CLINICAL-SIGNIFICANCE; ENRICHMENT; BIOMARKER; SURVIVAL;
D O I
10.21147/j.issn.1000-9604.2021.02.12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Hematogenous metastasis is essential for the progression of ovarian cancer (OC), and circulating tumor cells (CTCs) are part of the metastatic cascade. However, the detection rate of CTC is low due to the use of less sensitive detection methods. Therefore, this study aimed to detect CTCs and circulating tumorigenic endothelial cells (CTECs) in patients with OC using subtraction enrichment and immunostaining and fluorescence in situ hybridization (SE-iFISH). Methods: We enrolled a total of 56 subjects, including 20 OC patients and 36 ovarian benign tumor patients. CTCs and CTECs were captured by subtraction enrichment (SE) and counted and classified according to immunofluorescence staining of tumor markers (TMs) carbohydrate antigen 125 (CA125) and human epididymis protein 4 (HE4) combined with fluorescence in situ hybridization (iFISH) of chromosome 8 (Chr8) aneuploidy. The diagnostic value and subtype characteristics of CTCs and CTECs were investigated. Results: The detection rate of CTCs by SE-iFISH was high. Compared with CA125 and HE4, Chr8 aneuploidy was the major identification feature of CTC. CTC counts in OC were statistically higher than those in benign groups. CTC and CTEC with =pentaploidy were detected in both groups, illustrating the poor diagnostic value of CTC or CTEC. Distributions of triploid and tetraploid CTC subtypes were significantly different, and combined detection of triploid and tetraploid CTCs showed the best diagnostic value. In contrast, the distribution of CTECs in the OC and benign groups had no statistically significant difference. Small CTCs accounted for over 1/3 of the total CTC count. We also found that small CTCs and CTECs primarily comprised triploid cells, while large CTCs and CTECs mainly comprised pentaploidy and beyond. Conclusions: The application of SE-iFISH offered a more comprehensive understanding of heterogeneous CTCs and CTECs in OC. Analysis of subclass characteristics of the CTCs and CTECs according to Chr8 aneuploidy and cell size may broaden their potential clinical utility and deepen mechanistic studies in OC.
引用
收藏
页码:256 / 270
页数:15
相关论文
共 43 条
[1]   Ten-Year Relative Survival for Epithelial Ovarian Cancer [J].
Baldwin, Lauren A. ;
Huang, Bin ;
Miller, Rachel W. ;
Tucker, Thomas ;
Goodrich, Scott T. ;
Podzielinski, Iwona ;
DeSimone, Christopher P. ;
Ueland, Fred R. ;
van Nagell, John R. ;
Seamon, Leigh G. .
OBSTETRICS AND GYNECOLOGY, 2012, 120 (03) :612-618
[2]   Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study [J].
Behbakht, Kian ;
Sill, Michael W. ;
Darcy, Kathleen M. ;
Rubin, Stephen C. ;
Mannel, Robert S. ;
Waggoner, Steven ;
Schilder, Russell J. ;
Cai, Kathy Q. ;
Godwin, Andrew K. ;
Alpaugh, R. Katherine .
GYNECOLOGIC ONCOLOGY, 2011, 123 (01) :19-26
[3]   ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer [J].
Chebouti, Issam ;
Kuhlmann, Jan Dominik ;
Buderath, Paul ;
Weber, Stephan ;
Wimberger, Pauline ;
Bokeloh, Yvonne ;
Hauch, Siegfried ;
Kimmig, Rainer ;
Kasimir-Bauer, Sabine .
ONCOTARGET, 2017, 8 (15) :24303-24313
[4]   New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination [J].
Coffman, Lan G. ;
Burgos-Ojeda, Daniela ;
Wu, Rong ;
Cho, Kathleen ;
Bai, Shoumei ;
Buckanovich, Ronald J. .
TRANSLATIONAL RESEARCH, 2016, 175 :92-102
[5]   Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis [J].
Cui, Long ;
Kwong, Joseph ;
Wang, Chi Chiu .
JOURNAL OF OVARIAN RESEARCH, 2015, 8
[6]   Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization [J].
Gao, Yang ;
Zhu, Yayun ;
Zhang, Zhenzhen ;
Zhang, Cheng ;
Huang, Xinyu ;
Yuan, Zhou .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
[7]   Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells [J].
Ge, Feng ;
Zhang, Haishi ;
Wang, Daisy Dandan ;
Li, Linda ;
Lin, Peter Ping .
ONCOTARGET, 2015, 6 (29) :27049-27064
[8]  
Guo Yan-Xiu, 2018, Oncotarget, V9, P7522, DOI 10.18632/oncotarget.23943
[9]   Trisomy 8 in acute myeloid leukemia [J].
Hemsing, Anette Lodvir ;
Hovland, Randi ;
Tsykunova, Galina ;
Reikvam, Hakon .
EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (11) :947-958
[10]   Circulating tumour cells in prostate cancer [J].
Hille, Claudia ;
Pantel, Klaus .
NATURE REVIEWS UROLOGY, 2018, 15 (05) :265-+